Knowledge Center
Patent / Sep 01, 2013
Detoxification of Active Pharmaceutical Ingredients For Nano-Filtration
Source:
PT 105601
The invention describes the use of nanofiltration of org. solvents as a general platform for removing genotoxic impurities, also known as genotoxins, used as a reagent or formed during the synthesis of active pharmaceutical ingredients or their intermediates. The invention thus focuses, in particular, on the removal of the most common classes of genotoxic impurities using membranes.
Also in the Knowledge Center
/ Sep 01, 2023
In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting I: Experimental design for PermeaLoop
Read more
Scientific Article
/ Sep 01, 2023
In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting II: Comparison and mechanistic insights
Read more
Scientific Article
/ Aug 25, 2023
Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability
Read more
Scientific Article